Advances in Medicine (AIM) Grand Rounds
1. Review the current pathophysiology of OSAS
2. Analyze the systemic complications of OSAS
3. Discuss the pathophysiology process in leading the field to new therapies
4. Anticipate the future implications of the discipline
Target Audience: Physicians, Residents, Nurses, Fellows, Students
Accreditation: Winthrop University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Winthrop University Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
It is the policy of Winthrop-University Hospital to adhere to ACCME Accreditation Criteria, Policies and Standards for Commercial Support in order to ensure content validity, fair balance, independence, objectivity and scientific rigor in all its sponsored programs. All faculty, planners and authors of CME content, who participate in sponsored programs, must disclose to the audience any potential, apparent or real conflicts of interest related to their contribution to the activity, as well as any discussions of off-label or investigational uses of any commercial products or devices not yet approved in the United States. All disclosures will be made at the time of the activity. Please call Rob Martin, MBA, CHCP, Director of CME at 516-663-2521 to express any concerns.
Dr. Ahmed has nothing to disclose
Course Director: Bruce Polsky, MD has disclosed the following relevant financial relationships:
Scientific Consultant with consulting fees: CorMedix Inc.; Director, ATEA Pharmaceuticals; Spouse is employee of Bristol-Myers Squibb Company with salary, stock and stock options.
Planning Committee: Has disclosed the following relationships: Steve Carsons, MD, Salary/Royalty, or Honoraria: Nassau University Medical Ctr. and USL Inc. Receipt of Intellectual Property Rights/ Patent Holder: WUH, Supported/Contracted Research: Centocor Wyeth. John Maesaka, MD Consulting Fees: Pfizer Inc & Oksuka Pharmaceutical. Has nothing to Disclose: Mohammad Ali, MD, Burke Cunha MD, Christopher Garcia, MD, James Grendell MD, Irving Gomolin, MD, Jonathan Rodriguez, MD, Harry Staszewski, MD, Lori Spitz, RN, Kevin Marzo, MD, Steve Salzman, MD, Lawrence Shapiro, MD,
Acknowledgement of Commercial Support: N/A
Evaluations for Regularly Scheduled Series sessions are conducted on a semi-annual basis, each June and December. If you have questions or concerns regarding the content or presentation of this session please contact Peter Sandre: firstname.lastname@example.org